Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
JOURNALS
PSYCHOPHARMACOLOGY BULLETIN
FULL ISSUE STACKED PDFs
T.E.N.
MENTAL FITNESS
PSI
ONCOLOGY SPECTRUMS
PROJECTS
JOURNAL SUPPLEMENTS
PHYSICIAN ACADEMY SERIES
POCKET REFERENCE GUIDES
TEACHING MONOGRAPHS
MEDWORKS REPRINT SERIES
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOTROPIC PRESCRIBING INFORMATION
PSYCHOTROPIC DOSAGE RANGES
PSYCHOPHARMACOLOGY 101
PSYCHIATRIC RATING SCALES
NEWS
WE KNOW PSYCHIATRY
FEATURED ARTICLES
Home
C. Lindsay DeVane, PharmD: An Explanation of the Second-Dose Effect in Pharmacokinetics and Its Meaning for Clinical Psychopharmacology
C. Lindsay DeVane, PharmD: An Explanation of the Second-Dose Effect in Pharmacokinetics and Its Meaning for Clinical Psychopharmacology
$
30.00
C. Lindsay DeVane, PharmD: An Explanation of the Second-Dose Effect in Pharmacokinetics and Its Meaning for Clinical Psychopharmacology quantity
Add to cart
Want a discount? Become a member by purchasing
Psychopharmacology Bulletin Subscription - Individual
!
Categories:
Psychopharmacology Bulletin
,
VOL 35 No. 1 Articles
Tags:
c-lindsay-devane
,
dosage-regimen-design
,
heidi-l-liston
,
medworks-media
,
pharmacokinetics
,
psychopharmacology
,
psychopharmacology-bulletin
,
second-dose-effect
Description
Description
C. Lindsay DeVane, PharmD
DRUG INTERACTIONS
An Explanation of the Second-Dose Effect in Pharmacokinetics and Its Meaning for Clinical Psychopharmacology
C. Lindsay DeVane, PharmD, and Heidi L. Liston, PharmD
Related products
Long Acting Risperidone in an Adolescent – Mustafa Deniz Tutkunkardas
$
30.00
Add to cart
Details
Zonisamide for Bipolar Disorder, Mania or Mixed States by Deborah Dauphinais
$
30.00
Add to cart
Details
What Mood Symptoms may be most Difficult to Rate?
$
30.00
Add to cart
Details
Assessment of Anxiety in Clinical Trials with Depressed Patients
$
30.00
Add to cart
Details
Page load link
Go to Top
